Products

What will AGI do for Amifampridine?

This classification denotes a cation channel blocker with the molecular formula C5H7N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RU4S6E2G0J, chemically known as 3,4 DIAMINOPYRIDINE, but generally known as amifampridine. European Medicines Agency schedules amifampridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB28846. As of Q4 2014, AMIFAMPRIDINE remains the US FDA Preferred Term for this commodity. Amifampridine bears US NLM identifiers UMLS ID C0046948 and NCI Concept Code C82687. SMILES: none.

How AGI delivers it

Four ways AGI delivers for Amifampridine

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amifampridine, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amifampridine, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amifampridine connects

measured by

  • Assay Contentmodel
  • Assay Puritymodel
  • Compound Puritymodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Melting Pointmodel
  • Residual Solventmodel